Pulnovo Medical Completes Enrollment in Trial of Pulmonary Artery Denervation to Treat Hypertension
Cardiac Interventions Today,
June 28, 2021—Pulnovo Medical announced that the PADN-CFDA randomized controlled trial of the company’s pulmonary artery…